Претраживање
Приказ резултата 11-20 од 164
Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules / Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated ...
Modern therapy for inflammatory bowel disease / Savremena terapija inflamatorne bolesti creva
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Inflammatory bowel disease (IBD) is an idiopathic chronic disease. According to the latest data, about 2.5 million people in Europe, as well about 8 thousands in Serbia, have IBD. The main symptoms of this disease are ...
Pharmaceutical technological aspects and possibility of using transdermal patches in paediatric population / Farmaceutsko-tehnološki aspekt i mogućnosti primene transdermalnih flastera u pedijatriji
(Savez farmaceutskih udruženja Srbije, Beograd, 2014)
The administration of drugs via skin to achieve systemic effects is simple and noninvasive, and thus represents a more suitable alternative for pediatric population when compared with per os and parenteral routes. This ...
Body mass index and insulin resistance as independent predictors of hypertension in postmenopausal women / Indeks telesne mase i insulinska rezistencija kao nezavisni prediktori hipertenzije kod žena u postmenopauzi
(Srpsko lekarsko društvo - Podružnica Zaječar, Zaječar, 2017)
Aim: Although previous studies confirmed the association between obesity and hypertension, the underlying pathophysiological mechanism is not well elucidated, specially considering the fact that discordant results exist ...
Menopausal status as an independent predictor of high serum retinol-binding protein 4 levels / Menopauza kao nezavisni prediktor povišenih vrednosti retinolvezujućeg proteina 4 u serumu
(Srpsko lekarsko društvo - Podružnica Zaječar, Zaječar, 2017)
Aim: Retinol-binding protein 4 (RBP4) is a novel adipokine closely related to insulin resistance. However, data on the influence of menopausal status on serum RBP4 are scarce. Therefore, the aim of the current study was ...
Medicines in treatment of addictive disorders / Lekovi u terapiji bolesti zavisnosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
It is estimated that annual sales of illegal psychoactive substances account for 8% of total international trade. The large consumption of alcohol and tobacco, as socially accepted drugs, as well as of several classes of ...
Biological medicines: Three decades of progress / Biološki lekovi: Tri decenije razvoja
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Any medicine whose active substance is present in living organisms, or derived from living organisms, may be considered as a biological product. Vaccines, blood derivatives and products, or hormones isolated from animal ...
Lipid status in phyisiological non-complicated pregnancy / Lipidni status fiziološke nekomplikovane trudnoće
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Specifically altered lipid profile and physiological hyperlipidemia during pregnancy are considered essential for the normal course of pregnancy and fetal development. This specific alteration of the lipid profile raises ...
Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin / Farmakoekonomska evaluacija pružanja farmaceutske usluge pacijentima na antikoagulantnoj terapiji varfarinom
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
It has been determined that Pharmacist-Managed Anticoagulation Service (PMAS) for patients on warfarin improves anticoagulation control and decreases the rate of bleeding, thus reducing the overall health care costs. This ...
Drugs for rare diseases: An example of modified glucocerebrosidase / Lekovi za retke bolesti - primer modifikovane glukocerebrozidaze
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
To date, circa 5000 rare diseases have been defined, which in sum affect approximately 6% of total population. The development of drugs for rare diseases is hampered by the limitation of specific knowledge availability and ...